# RIVASTIGMINE TARTRATE

NDC: 75834-133
Generic name: RIVASTIGMINE TARTRATE
Labeler / Manufacturer: Nivagen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20170904

FDA application: ANDA203844

## Active ingredients

- RIVASTIGMINE TARTRATE: 1.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75834-133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75834-133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1